BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35726125)

  • 21. IL-6 induced lncRNA MALAT1 enhances TNF-α expression in LPS-induced septic cardiomyocytes via activation of SAA3.
    Zhuang YT; Xu DY; Wang GY; Sun JL; Huang Y; Wang SZ
    Eur Rev Med Pharmacol Sci; 2017 Jan; 21(2):302-309. PubMed ID: 28165557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA MALAT1 knockdown alleviates myocardial apoptosis in rats with myocardial ischemia-reperfusion through activating PI3K/AKT signaling pathway.
    Sun T; Cheng YT; Yan LX; Krittanawong C; Qian W; Zhang HJ
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10523-10531. PubMed ID: 31841208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNA MALAT1 regulates cardiomyocytes apoptosis after hypoxia/reperfusion injury via modulating miR-200a-3p/PDCD4 axis.
    Sun R; Zhang L
    Biomed Pharmacother; 2019 Mar; 111():1036-1045. PubMed ID: 30841417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EZH2 RIP-seq Identifies Tissue-specific Long Non-coding RNAs.
    Wang Y; Xie Y; Li L; He Y; Zheng D; Yu P; Yu L; Tang L; Wang Y; Wang Z
    Curr Gene Ther; 2018; 18(5):275-285. PubMed ID: 30295189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. lncRNA TUG1 inhibits the cancer stem cell‑like properties of temozolomide‑resistant glioma cells by interacting with EZH2.
    Cao Y; Chai W; Wang Y; Tang D; Shao D; Song H; Long J
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34036375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of lncRNA MALAT1 on septic lung injury in mice through p38 MAPK/p65 NF-κB pathway.
    Lin LP; Niu GH; Zhang XQ
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1296-1304. PubMed ID: 30779099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205.
    Hirata H; Hinoda Y; Shahryari V; Deng G; Nakajima K; Tabatabai ZL; Ishii N; Dahiya R
    Cancer Res; 2015 Apr; 75(7):1322-31. PubMed ID: 25600645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 attenuates high glucose-induced cardiomyocyte apoptosis via regulation of miR-181a-5p.
    Cheng Y; Li J; Wang C; Yang H; Wang Y; Zhan T; Guo S; Liang J; Bai Y; Yu J; Liu G
    Exp Anim; 2020 Jan; 69(1):34-44. PubMed ID: 31353329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long non-coding RNA MALAT1 promotes cardiac remodeling in hypertensive rats by inhibiting the transcription of MyoD.
    Li D; Zhang C; Li J; Che J; Yang X; Xian Y; Li X; Cao C
    Aging (Albany NY); 2019 Oct; 11(20):8792-8809. PubMed ID: 31619581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long noncoding RNA MALAT1 promotes malignant development of esophageal squamous cell carcinoma by targeting β-catenin via Ezh2.
    Wang W; Zhu Y; Li S; Chen X; Jiang G; Shen Z; Qiao Y; Wang L; Zheng P; Zhang Y
    Oncotarget; 2016 May; 7(18):25668-82. PubMed ID: 27015363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long noncoding RNA NEAT1 suppresses hepatocyte proliferation in fulminant hepatic failure through increased recruitment of EZH2 to the LATS2 promoter region and promotion of H3K27me3 methylation.
    Wang Q; Liu L; Zhang S; Ming Y; Liu S; Cheng K; Zhao Y
    Exp Mol Med; 2020 Mar; 52(3):461-472. PubMed ID: 32157157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel long noncoding RNA-lncRNA-AABR07066529.3 alleviates inflammation, apoptosis, and pyroptosis by inhibiting MyD88 in lipopolysaccharide-induced myocardial depression.
    Wen R; Zhang TN; Zhang T; Tong YJ; Song WL; Liu YP; Yang N; Liu CF
    FASEB J; 2023 Aug; 37(8):e23063. PubMed ID: 37401890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LncRNA MALAT1 Promotes Oxygen-Glucose Deprivation and Reoxygenation Induced Cardiomyocytes Injury Through Sponging miR-20b to Enhance beclin1-Mediated Autophagy.
    Wang S; Yao T; Deng F; Yu W; Song Y; Chen J; Ruan Z
    Cardiovasc Drugs Ther; 2019 Dec; 33(6):675-686. PubMed ID: 31823095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MALAT1 long ncRNA promotes gastric cancer metastasis by suppressing PCDH10.
    Qi Y; Ooi HS; Wu J; Chen J; Zhang X; Tan S; Yu Q; Li YY; Kang Y; Li H; Xiong Z; Zhu T; Liu B; Shao Z; Zhao X
    Oncotarget; 2016 Mar; 7(11):12693-703. PubMed ID: 26871474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA MALAT1 facilitates inflammasome activation via epigenetic suppression of Nrf2 in Parkinson's disease.
    Cai LJ; Tu L; Huang XM; Huang J; Qiu N; Xie GH; Liao JX; Du W; Zhang YY; Tian JY
    Mol Brain; 2020 Sep; 13(1):130. PubMed ID: 32972446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ppp1r1b-lncRNA inhibits PRC2 at myogenic regulatory genes to promote cardiac and skeletal muscle development in mouse and human.
    Kang X; Zhao Y; Van Arsdell G; Nelson SF; Touma M
    RNA; 2020 Apr; 26(4):481-491. PubMed ID: 31953255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA NEAT1 alleviates sepsis-induced myocardial injury by regulating the TLR2/NF-κB signaling pathway.
    Wang SM; Liu GQ; Xian HB; Si JL; Qi SX; Yu YP
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4898-4907. PubMed ID: 31210324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers.
    Au SL; Wong CC; Lee JM; Wong CM; Ng IO
    PLoS One; 2013; 8(6):e68226. PubMed ID: 23826380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of EZH2 primes the cardiac gene activation via removal of epigenetic repression during human direct cardiac reprogramming.
    Tang Y; Zhao L; Yu X; Zhang J; Qian L; Jin J; Lu R; Zhou Y
    Stem Cell Res; 2021 May; 53():102365. PubMed ID: 34087994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MALAT1 predicts poor survival in osteosarcoma patients and promotes cell metastasis through associating with EZH2.
    Huo Y; Li Q; Wang X; Jiao X; Zheng J; Li Z; Pan X
    Oncotarget; 2017 Jul; 8(29):46993-47006. PubMed ID: 28388584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.